Radiomics in Musculoskeletal Tumors

Semin Musculoskelet Radiol. 2024 Feb;28(1):49-61. doi: 10.1055/s-0043-1776428. Epub 2024 Feb 8.ABSTRACTSarcomas are heterogeneous rare tumors predominantly affecting the musculoskeletal (MSK) system. Due to significant variations in their natural history and variable response to conventional treatments, the discovery of novel diagnostic and prognostic biomarkers to guide therapeutic decision-making is an active and ongoing field of research. As new cellular, molecular, and metabolic biomarkers continue to be discovered, quantitative radiologic imaging is becoming increasingly important in sarcoma management. Radiomics offers the potential for discovering novel imaging diagnostic and predictive biomarkers using standard-of-care medical imaging. In this review, we detail the core concepts of radiomics and the application of radiomics to date in MSK sarcoma research. Also described are specific challenges related to radiomic studies, as well as viewpoints on clinical adoption and future perspectives in the field.PMID:38330970 | DOI:10.1055/s-0043-1776428
Source: Nuklearmedizin - Category: Radiology Authors: Source Type: research